{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:46:31Z","timestamp":1792554391887,"version":"4.5.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["DTA studentship"],"award-info":[{"award-number":["DTA studentship"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EPSRC Doctoral Prize Fellowship (X\/013296)"],"award-info":[{"award-number":["EPSRC Doctoral Prize Fellowship (X\/013296)"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["Impact Acceleration Account (X\/167000)"],"award-info":[{"award-number":["Impact Acceleration Account (X\/167000)"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oral. Health"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a growing problem without an effective treatment, presenting as necrotic bone sections exposed via lesions in the overlying soft tissue. There is currently a lack of clarity on how the factors involved in MRONJ development and progression contribute to disease prognosis and outcomes. Bisphosphonates (BPs), the most common cause of MRONJ, affect bone remodeling, angiogenesis, infection, inflammation and soft tissue toxicity, all of which contribute to MRONJ development. This article reviews the cellular mechanisms through which BPs contribute to MRONJ pathology, with a focus on the effects on cells of the oral mucosa. BPs have been shown to reduce cell viability, reduce proliferation, and increase apoptosis in oral keratinocytes and fibroblasts. BPs have also been demonstrated to reduce epithelial thickness and prevent epithelial formation in three-dimensional tissue engineered models of the oral mucosa. This combination of factors demonstrates how BPs lead to the reduced wound healing seen in MRONJ and begins to uncover the mechanisms through which these effects occur. The evidence presented here supports identification of targets which can be used to develop novel treatment strategies to promote soft tissue wound healing and restore mucosal coverage of exposed bone in MRONJ.<\/jats:p>","DOI":"10.3389\/froh.2021.822411","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T23:53:10Z","timestamp":1644364390000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw"],"prefix":"10.3389","volume":"2","author":[{"given":"George","family":"Bullock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"McKechnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hearnden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-\u22122014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115570","DOI":"10.1016\/j.bone.2020.115570","article-title":"Bisphosphonates and breast cancer\u2014From cautious palliation to saving lives","volume":"140","author":"Coleman","year":"2020","journal-title":"Bone."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1039\/C5OB01967B","article-title":"Synthesis of novel polymerizable molecules bearing bisphosphonate","volume":"13","author":"Kachbi Khelfallah","year":"2015","journal-title":"Org Biomol Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","article-title":"Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts","volume":"56","author":"Ravosa","year":"2011","journal-title":"Arch Oral Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bjoms.2014.11.008","article-title":"United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis","volume":"53","author":"Rogers","year":"2015","journal-title":"Br J Oral Maxillofac Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.4149\/BLL_2017_137","article-title":"Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease","volume":"118","author":"Galis","year":"2017","journal-title":"Bratislava Med J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int J Implant Dent."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bjoms.2014.09.001","article-title":"Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed","volume":"53","author":"Fedele","year":"2015","journal-title":"Br J Oral Maxillofac Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw\u2014current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/ger.12093","article-title":"Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review","volume":"32","author":"Iglesias","year":"2015","journal-title":"Gerodontology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1348-8643(12)00045-6","article-title":"Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw","volume":"10","author":"Ikebe","year":"2013","journal-title":"Oral Sci Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/adj.12648","article-title":"\u201cSpontaneous\u201d medication-related osteonecrosis of the jaw; two case reports and a systematic review","volume":"63","author":"Khominsky","year":"2018","journal-title":"Aust Dent J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jcms.2017.07.002","article-title":"Further development of the MRONJ minipig large animal model","volume":"45","author":"Otto","year":"2017","journal-title":"J Cranio Maxillofacial Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone."},{"key":"B17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4081\/oncol.2014.254","article-title":"Bisphosphonate-related osteonecrosis of the jaw: specificities","volume":"8","author":"Paulo","year":"2014","journal-title":"Oncol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jcms.2015.04.026","article-title":"Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model","volume":"43","author":"Barba-Recreo","year":"2015","journal-title":"J Craniomaxillofac Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.archoralbio.2015.05.015","article-title":"Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis","volume":"60","author":"Silva PG de","year":"2015","journal-title":"Arch Oral Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J Craniomaxillofac Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/jbmr.4119","article-title":"A drug holiday reduces the frequency and severity of medication-related osteonecrosis of the jaw in a minipig model","volume":"35","author":"Otto","year":"2020","journal-title":"J Bone Miner Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1016\/j.jcms.2012.01.028","article-title":"Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo","volume":"40","author":"Draenert","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/sj.bdj.2015.444","article-title":"Jaw problems: update on ARONJ","volume":"218","author":"Kyriakidou","year":"2015","journal-title":"Br Dent J."},{"key":"B26","unstructured":"Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease17938\n            SivolellaS\n            LumachiF\n            StelliniE\n            FaveroL\n          23645723Anticancer Res.332013"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"49","author":"Ebetino","year":"2011","journal-title":"Bone."},{"key":"B29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone."},{"key":"B30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1196\/annals.1346.041","article-title":"Bisphosphonates: from bench to bedside","volume":"1068","author":"Russell","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40902-015-0015-3","article-title":"Combined effect of bisphosphonate and recombinant human bone morphogenetic protein 2 on bone healing of rat calvarial defects","volume":"37","author":"Kim","year":"2015","journal-title":"Maxillofac Plast Reconstr Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/TCRM.S35788","article-title":"Clinical development of neridronate: potential for new applications","volume":"9","author":"Gatti","year":"2013","journal-title":"Ther Clin Risk Manag."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+&lt;2961::AID-CNCR12&gt;3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S8756-3282(01)00412-4","article-title":"Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro","volume":"28","author":"Benford","year":"2001","journal-title":"Bone."},{"key":"B35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"The efficacy of pamidronate in reducing skeletal associated events in patients with advanced multiple myeloma","volume":"334","author":"Berenson","year":"1996","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-05-0264","article-title":"Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity","volume":"65","author":"Cl\u00e9zardin","year":"2005","journal-title":"Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ctrv.2011.09.003","article-title":"Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature","volume":"38","author":"Gnant","year":"2012","journal-title":"Cancer Treat Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr2769","article-title":"Anti-tumour activity of bisphosphonates in preclinical models of breast cancer","volume":"12","author":"Holen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"2015","author":"Katsarelis","year":"","journal-title":"J Dent Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajoms.2017.08.004","article-title":"Risk factors and treatments for medication-related osteonecrosis of the jaw: a 10-year single-institution experience","volume":"30","author":"Matsuda","year":"2017","journal-title":"J Oral Maxillofac Surg Med Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ijos.2014.46","article-title":"Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"Pushalkar","year":"2014","journal-title":"Int J Oral Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone."},{"key":"B44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fphys.2016.00507","article-title":"Wound healing problems in the mouth","volume":"7","author":"Politis","year":"2016","journal-title":"Front Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00784-012-0800-7","article-title":"Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid","volume":"17","author":"Mozzati","year":"2013","journal-title":"Clin Oral Investig."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.joms.2011.05.002","article-title":"Effects of pamidronate on human alveolar osteoblasts in vitro","volume":"70","author":"Marolt","year":"2012","journal-title":"J Oral Maxillofac Surg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00520-009-0710-7","article-title":"A novel bioassay model to determine clinically significant bisphosphonate levels","volume":"17","author":"Scheper","year":"2009","journal-title":"Support Care Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9858921","article-title":"Microsurgical reconstruction of the jaws using vascularised free flap technique in patients with medication-related osteonecrosis: a systematic review","volume":"2018","author":"Sacco","year":"2018","journal-title":"Biomed Res Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jcms.2017.12.015","article-title":"Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells","volume":"46","author":"A\u00e7il","year":"2018","journal-title":"J Cranio Maxillofacial Surg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jcms.2015.03.014","article-title":"The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: an in vitro study","volume":"43","author":"Pabst","year":"2015","journal-title":"J Cranio Maxillofacial Surg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jcms.2019.06.004","article-title":"Gingival fibroblasts and medication-related osteonecrosis of the jaw: results by real-time and wound healing in vitro assays","volume":"47","author":"Yuan","year":"2019","journal-title":"J Cranio Maxillofacial Surg."},{"key":"B54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/wound.2013.0473","article-title":"Epithelialization in wound healing: a comprehensive review","volume":"3","author":"Pastar","year":"2014","journal-title":"Adv Wound Care."},{"key":"B55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.joms.2011.03.005","article-title":"Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts","volume":"69","author":"Cozin","year":"2011","journal-title":"J Oral Maxillofac Surg."},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J Bone Miner Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0022034511402995","article-title":"bisphosphonates induce senescence in normal human oral keratinocytes","volume":"90","author":"Kim","year":"2011","journal-title":"J Dent Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1177\/0960327115569808","article-title":"Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts","volume":"34","author":"Soydan","year":"2015","journal-title":"Hum Exp Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/ma12111840","article-title":"Synthetic calcium phosphate ceramics as a potential treatment for bisphosphonate-related osteonecrosis of the jaw","volume":"12","author":"Paulo","year":"2019","journal-title":"Materials."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/ma13092086","article-title":"Synthetic hydroxyapatite inhibits bisphosphonate toxicity to the oral mucosa in vitro","volume":"13","author":"Bullock","year":"2020","journal-title":"Materials."},{"key":"B62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ijmm.2016.2582","article-title":"Zoledronic acid suppresses transforming growth factor-induced fibrogenesis by human gingival fibroblasts","volume":"38","author":"Komatsu","year":"2016","journal-title":"Int J Mol Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.37358\/RC.19.9.7542","article-title":"Comparative effects of oral and injectable bisphosphonates in primary human gingival fibroblasts","volume":"70","author":"Balean","year":"2019","journal-title":"Rev Chim."},{"key":"B64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0022034509354298","article-title":"Is zoledronate toxic to human periodontal fibroblasts?","volume":"89","author":"Agis","year":"2010","journal-title":"J Dent Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","article-title":"Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation","volume":"19","author":"Hagelauer","year":"2015","journal-title":"Clin Oral Investig."},{"key":"B66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br J Haematol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","article-title":"Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells","volume":"14","author":"Walter","year":"2010","journal-title":"Clin Oral Investig."},{"key":"B68","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/jop.12181","article-title":"Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts","volume":"43","author":"Zafar","year":"2014","journal-title":"J Oral Pathol Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.7150\/ijms.36994","article-title":"Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts","volume":"16","author":"Manzano-Moreno","year":"2019","journal-title":"Int J Med Sci."},{"key":"B70","volume-title":"Tissue engineering approaches to the treatment of bisphosphonate-related osteonecrosis of the jaw","author":"Bullock","year":"2019"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00784-018-2349-6","article-title":"Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro","volume":"22","author":"Jung","year":"2018","journal-title":"Clin Oral Investig."},{"key":"B72","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.joms.2013.08.007","article-title":"In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts","volume":"72","author":"McLeod","year":"2014","journal-title":"J Oral Maxillofac Surg."},{"key":"B73","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00784-017-2167-2","article-title":"Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces","volume":"22","author":"Basso","year":"2017","journal-title":"Clin Oral Investig."},{"key":"B74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","article-title":"The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes-in vitro study","volume":"16","author":"Pabst","year":"2012","journal-title":"Clin Oral Investig."},{"key":"B75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1601-0825.2012.01971.x","article-title":"In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells","volume":"19","author":"Arai","year":"2013","journal-title":"Oral Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.archoralbio.2011.11.015","article-title":"Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes","volume":"57","author":"Ohnuki","year":"2012","journal-title":"Arch Oral Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"700","DOI":"10.12659\/MSM.911579","article-title":"Epidermal growth factor reverses the inhibitory effects of the bisphosphonate, zoledronic acid, on human oral keratinocytes and human vascular endothelial cells in vitro via the Epidermal Growth Factor Receptor (EGFR)\/Akt\/Phosphoinositide 3-Kinase (PI3K)","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit."},{"key":"B78","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1742-481X.2011.00905.x","article-title":"Low concentration amino-bisphosphonates stimulate human keratinocyte proliferation and in vitro wound healing","volume":"9","author":"Ren\u00f2","year":"2012","journal-title":"Int Wound J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","article-title":"Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics","volume":"20","author":"Dickson","year":"2000","journal-title":"Mol Cell Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp Dermatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1464-4096.2004.04831.x","article-title":"Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation","volume":"94","author":"Coxon","year":"2004","journal-title":"BJU Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"4351327","DOI":"10.1155\/2019\/4351327","article-title":"Geranylgeraniol (GGOH) as a mevalonate pathway activator in the rescue of bone cells treated with zoledronic acid: an in vitro study","volume":"2019","author":"Fliefel","year":"2019","journal-title":"Stem Cells Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat Protoc."},{"key":"B84","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2008.10.043","article-title":"Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells","volume":"602","author":"Wu","year":"2009","journal-title":"Eur J Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"43603","DOI":"10.1074\/jbc.M308114200","article-title":"Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B\/Akt","volume":"278","author":"Bezzi","year":"2003","journal-title":"J Biol Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1538-7836.2006.02259.x","article-title":"Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways","volume":"5","author":"Hasmim","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B87","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/10623320701347187","article-title":"Zoledronate inhibits \u03b1v\u03b23 and \u03b1v\u03b25 integrin cell surface expression in endothelial cells","volume":"14","author":"Bellahc\u00e8ne","year":"2007","journal-title":"Endothelium."},{"key":"B88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jbo.2014.02.001","article-title":"Zoledronic acid and atorvastatin inhibit \u03b1v\u03b23-mediated adhesion of breast cancer cells","volume":"3","author":"Wilke","year":"2014","journal-title":"J Bone Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jcp.1093","article-title":"Phosphorylation of focal adhesion kinase (pp125FAK) is increased in human keratinocytes induced to migrate by extracellular matrices","volume":"188","author":"Yurko","year":"2001","journal-title":"J Cell Physiol."},{"key":"B91","unstructured":"Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells92732\n            MatsunagaS\n            IguchiK\n            UsuiS\n            HiranoK\n          17465222Anticancer Res.272007"},{"key":"B92","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijom.2013.06.016","article-title":"Zoledronic acid impairs re-epithelialization through down-regulation of integrin \u03b1v\u03b26 and transforming growth factor beta signalling in a three-dimensional in vitro wound healing model","volume":"43","author":"Saito","year":"2014","journal-title":"Int J Oral Maxillofac Surg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/emboj\/cdf399","article-title":"Role of integrins in regulating epidermal adhesion, growth and differentiation","volume":"21","author":"Watt","year":"2002","journal-title":"EMBO J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/odi.12154","article-title":"Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa","volume":"20","author":"Donetti","year":"2014","journal-title":"Oral Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/bjc.2011.403","article-title":"Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma","volume":"105","author":"Colley","year":"2011","journal-title":"Br J Cancer."},{"key":"B96","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/ijmm.2014.1802","article-title":"Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue","volume":"34","author":"Bae","year":"2014","journal-title":"Int J Mol Med."}],"container-title":["Frontiers in Oral Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2021.822411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T23:53:16Z","timestamp":1644364396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2021.822411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":96,"alternative-id":["10.3389\/froh.2021.822411"],"URL":"https:\/\/doi.org\/10.3389\/froh.2021.822411","relation":{},"ISSN":["2673-4842"],"issn-type":[{"value":"2673-4842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"822411"}}